Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
90 years of
Hyaluronic Acid
Discover our
White Paper and explore the fascinating journey of this molecule !
HTL Biotechnology’s newly launched White Paper
To celebrate 90 years of this remarkable discovery, HTL Biotechnology recently launched its White Paper, which is an embodiment of our expertise and global leadership as a developer and manufacturer of pharmaceutical grade Hyaluronic Acid.
This 70-page book covers a range of topics related to Hyaluronic Acid, including:
- The evolution of Hyaluronic Acid since its discovery, as well as its current and future applications in medicine and aesthetics.
- The chemical structure of HA and its impact on biological functions such as hydration and healing.
- Ongoing research to optimise HA's therapeutic potential.
- The innovations surrounding HA that will shape its use in the future.
The history and evolution of a versatile molecule
Tracing the journey of Hyaluronic Acid starting from the laboratory to applications in medicine
1934
Discovery of HA by Karl Meyer and John Palmer
1966
First use in animal health in horses (arthropathy)
1972
First use in humans (osteoarthritis)
1979
First marketing authorisation in ophthalmology (cataracts)
1987
First approval by healthcare agencies in osteoarthritis indication
1990 onwards
Emergence of use in medical aesthetics and cosmetic procedures
